Iron Horse Wealth Management’s Gilead Sciences GILD Stock Holding History

Iron Horse Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$10.1K	Hold	91	–	–	﹤0.01%	279
2025 Q1	$10.2K	Hold	91	–	–	﹤0.01%	266
2024 Q4	$8.41K	Hold	91	–	–	﹤0.01%	258
2024 Q3	$7.63K	Hold	91	–	–	﹤0.01%	264
2024 Q2	$6.24K	Sell	91 -10	-10%	-$667	﹤0.01%	255
2024 Q1	$7.4K	Hold	101	–	–	﹤0.01%	226
2023 Q4	$8.18K	Hold	101	–	–	﹤0.01%	212
2023 Q3	$7.57K	Buy	101 +51	+102%	+$3.92K	﹤0.01%	216
2023 Q2	$3.85K	Hold	50	–	–	﹤0.01%	195
2023 Q1	$4.15K	Hold	50	–	–	﹤0.01%	214
2022 Q4	$4K	Buy	50 +40	+400%	+$3.17K	﹤0.01%	165
2022 Q3	$1K	Sell	10 -40	-80%	-$2.52K	﹤0.01%	120
2022 Q2	$3K	Hold	50	–	–	﹤0.01%	172
2022 Q1	$3K	Hold	50	–	–	﹤0.01%	180
2021 Q4	$4K	Buy	50 +40	+400%	+$2.75K	﹤0.01%	153
2021 Q3	$1K	Hold	10	–	–	﹤0.01%	174
2021 Q2	$1K	Hold	10	–	–	﹤0.01%	173
2021 Q1	$1K	Hold	10	–	–	﹤0.01%	166
2020 Q4	$1K	Buy	+10	New	+$603	﹤0.01%	157

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Iron Horse Wealth Management's GILD Position: Q2 2025 in Review

Iron Horse Wealth Management held its Gilead Sciences (GILD) position steady in Q2 2025 at 91 shares worth $10.1K. The position accounts for ﹤0.01% of the portfolio, ranked #279.

Iron Horse Wealth Management first reported a position in GILD in Q4 2020 and has held it in 19 quarters since. The position peaked at $10.2K in Q1 2025. 2,023 funds tracked by Wall St. Rank hold GILD as of Q2 2025.

Iron Horse Wealth Management held 91 shares of Gilead Sciences worth $10.1K as of Q2 2025.
Iron Horse Wealth Management left its Gilead Sciences share count unchanged in Q2 2025.
Gilead Sciences made up ﹤0.01% of Iron Horse Wealth Management's portfolio in Q2 2025, its #279 holding.
Iron Horse Wealth Management first reported a position in Gilead Sciences in Q4 2020 and has held it in 19 quarters since.
Iron Horse Wealth Management's Gilead Sciences position peaked at $10.2K in Q1 2025.
2,023 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2025.

Based on Iron Horse Wealth Management's 13F filing for Q2 2025, filed 22 Jul 2025.